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Abstract 
The pathogenesis of diabetes mellitus involves a low-level inflammatory process due to the increase of blood glucose. In this 
research, testing of extracted rosella was done on Spraque Dawley rats inducing by streptozotocin. The rats were divided into six 
groups i.e normal rats (SG), diabetic rats group (DiW, DiR1, DiR2), preventive rats (PR1)  and group  were diabetic rats given 
glibenclamide (DiG).  Analysis of inflammatory (TNF-α and IL-6) was performed on the spleen of rat using the ELISA 
technique. The results showed that roselle extract tended to decrease levels of the inflammatory TNF-α in diabetic rats, but could 
not be able to reduce the levels of IL-6. 
© 2014 The Authors. Published by Elsevier Ltd.  
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INTRODUCTION 
Diabetes mellitus (DM) is a metabolic disorder syndrome of carbohydrates, fats, and proteins caused by 
reduced insulin secretion or decreased tissue sensitivity to insulin. DM can be classified into two types, namely type 
1 and type 2 of diabetes mellitus.  DM type 2 is also called (non insulin-dependent diabetes mellitus, NIDDM), 
which is caused by decreasing in the sensitivity of target tissues to the metabolic effects of insulin.  
Of all cases in diabetes, approximately 90% that tends often to be found is diabetes mellitus type 2. In both 
types of diabetes, metabolism of all major nutrients becomes disorder. Resistance or absence of insulin will reduce 
the efficiency of the use and uptake of glucose by most of the body cells, excepting the brain cell. In DM, disorders 
of carbohydrate metabolism can cause hyperglycemia. Disorders in either the secretion or activity of insulin in 
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diabetes mellitus could be caused by non-enzymatic glycation mechanism, which is the processes of glucose 
chemically binding to the free amino group on the protein without helping of enzymes, as well as increasing of 
inflammation. Inflammation is a physiological response of the body against damage or disturbance outside factors. 
Hyperglycemia condition caused the response of inflammatory compounds that mediated by cytokines. The 
presence of cytokines will damage the insulin sensitivity and glucose balance [1]. Inflammation occurs after 
increasing blood glucose that is marked by an increase of various markers of inflammation,  such as high sensitivity 
C reactive protein (hs-CRP), interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α) and interleukin-18 (IL -18) [2,3]. 
Inflammation can be triggered through increase of ROS(reactive oxygen species) during diabetes mellitus. ROS can 
activate NF-κB, which is a transcription factor that regulates the expression of proinflammatory genes such as TNF-
α, IL-6 and C reactive protein. In addition, the condition of diabetes can increase the availability of free fatty acids 
due to lipolysis process. The increase of free fatty acids will activate the immune system for releasing cytokines IL-
6, TNF-α, IL-1β. It also explains the link between obesity and the increase of inflammation.   
TNF-α and IL-6, inflammatory compounds, are released by adipose cells and immune cells (neutrophils, 
macrophages), and muscle cells. Nearly 30% of IL-6 is released by visceral adipose tissue. TNF-α plays a role in 
apoptosis of microvascular in DM type 1 and 2, was involved in the pathogenesis of diabetic nepropathy and 
retinopathy [4]. Inflammation causes not only insulin resistance which can worsen the condition of diabetes but also 
dysfunction of β cells [5,6].  
Consumption increase of natural antioxidants can suppress the excess of inflammation [7,8,9,10]. The 
purpose of this study was to determine the capability of the extracted roselle toward decreasing levels of 
inflammatory compounds existing in diabetic rats. 
Benefits of the research was to provide information about Roselle as anti-inflammatory properties that will 
contribute to the roselle functions on other degenerative diseases such as obesity,  heart disease and atherosclerosis. 
 
MATERIALS AND METHODS 
Materials 
The main used material was purple petals of roselle (Hibiscus sabdariffa Linn) obtaining from roselle 
plantation in Leuwiliang, Bogor. Male rats from Sprague Dawley strain (200-250g / head) with a-2-month age were 
used as experimental animals. Rats  were obtained from BPPOM, Jakarta. inflammatory compounds were analyzed 
using immunochemical method (using a commercial kit of tumor necrosis factor alpha (TNF-α) from Biorbyt, UK 
with the catalog no. orb50113 and interleukin 6 (IL-6) from Biorbyt, UK with catalog no.orb50053, and BCA kit for 
protein content analysis. The main equipments for measuring the protein content of spleen fractions, and 
measurement of IL-6 and TNF-α  were a micropipette (Eppendorf) and a microplate reader. 
Methods 
Extraction of roselle 
 Extracted Roselle was made by boiling dry roselle as much as 1% in water for 10 minutes and then filtered. 
Extracted roselle was concentrated using a vacuum evaporator for 10 times. 
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Experimental Design 
 Grouping for experiment was divided into six groups which one group comprised of four rats. Six groups 
for experiment consisted of (1) Group of rats was not induced with streptozotocin and given distilled water (SG); (2) 
Group of rats was induced with streptozotocin and given a-dose-0.45 mg/kg bw of glibenclamide suspending in 
distilled water (DiG); (3) Groups of rats were induced with streptozotocin and given distilled water (DiW); (4) 
Group of rats was fed extracted roselle for 11 days and then induced with streptozotocin before giving extracted 
roselle for a-21-day treatment period (PR1); (5) Group of rats was induced with streptozotocin and given roselle 
extract (72 mg / day / 200 g wb) (DiR1); and (6) Group of rats was induced with streptozotocin and given roselle 
extract (288 mg / day / 200 g wb) (DiR2). 
Rats were injected intraperitoneally with a-35-mg / kg wb-dose of streptozotocin in 0.1 M cold citrate 
buffer (pH 4.5) [11]. After 72 hours of injection, the tail of rats was given  alcohol 70% and tested blood glucose 
levels  using a blood glucose test meter (Accu check).  A rat will suffer diabetes if its blood glucose level > 200 
mg/dl 
Before being given treatment, rats adapted during the first seven days. During adaptation period, all rats 
were treated with the same standard diet.  After seven days, treatment rats were given treatment based on six 
selected groups for 21 days. Drinking was given ad libitum. Feed for a rat was given more or less 25 g per day. A rat 
was weighted two days once. Residual feed was measured every day for checking how much treatment feed 
consumed every day. 
The roselle extract was administered 2 ml/day orally.  During treatment period, glucose levels were 
measured 2 or 3 times in all groups of treated rats. At the end of the treatment period, all rats were anaesthetized 
with ether, and the body was cleaned by alcohol. Further, the peritoneal was opened, and blood was sampled by 
using the syrinx.   Rat spleen was washed in a PBS (phosphate buffered saline) solution, then drained and weighted. 
The organs were then wrapped in aluminum foil and stored in a freezer at -20ºC [12]. 
Analysis Method 
Insulin 
 Insulin assay was transformed in a commercial kit (Biorbyt ORB54820, USA) using a sample of mouse 
blood plasma. This assay is a two site ELISA. The microplate  was precoated with a monoclonal antibody against 
insulin.  Standard and samples  were added into the wells and co-incubated with a monoclonal antibody conjugated 
to horseradish peroxidase (HRP) enzyme.  After washing step to remove any unbound substances, TMB substrate 
was added and colour develops in proportion to the amount of insulin bound initially.   
Sample Preparation for Inflammatory Compounds Analysis.  
A number of spleen samples (approximately 0.1 g) was weighted and added to 1 ml of PBS solution. Samples were 
milled until smooth, then centrifuged 4500 rpm 4 ° C for 10 minutes. The resulting supernatant was analyzed for 
levels of the protein. Measurement of protein levels was conducted using Bichinconinic acid (BCA). TNF alpha was 
analyzed using the kit catalog orb50113 of Biorbyt UK, while IL6 was analyzed using a kit catalog orb50053 of 
Biorbyt UK. 
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Biorbyt’s mouse TNF-α and IL-6 ELISA Kit were based on standard sandwich enzyme-linked immune-sorbent 
assay technology. Mouse TNFα and IL-6 specific-specific monoclonal antibodies were precoated onto 96-well 
plates. The mouse specific detection polyclonal antibodies were biotinylated. The samples test and biotinylated 
detection antibodies were added to the wells subsequently and then followed by washing with PBS or TBS buffer. 
Avidin-Biotin-Peroxidase Complex was added and unbound conjugates were washed away with PBS or TBS buffer. 
HRP substrate TMB was used to visualize HRP enzymatic reaction. TMB was catalyzed by HRP to produce a blue 
color product that changed into yellow after adding acidic stop solution. The density of yellow was proportional to 
the mouse TNFα amount of sample captured in plate. Inflammatory compound was determined using previous 
method [13] 
RESULT AND DISCUSSION 
Diabetes was characterized by increased levels of blood glucose. The blood glucose data were derived from 
the calculation of average blood sugar level on 4 rats during the treatment period as shown in Figure 1.  In Figure 1,  
7th day was the induction day with  STZ and after 2-3 days rats were hyperglycemic indicated by an increase of 
blood glucose >200 mg/dl. 
 
 
Figure 1.Average of  blood glucose of treated rats (day 1 first level of blood glucose ;  day 7, STZ induction, the 9th-21th day  treatment time 
with roselle (DiR1,DiR2); with glibenclamide (DiG); control (SG) and negative  (DiW). 
 
Figure 1 showed that rats with given roselle extract 72 mg/ml/200g wb (DiR1) had a decrease of blood 
glucose level on the 14th day, but then increased again until the end of the research period. Meanwhile rats with 
given roselle extract 288 mg/ml/200g wb (DiR2) had a decrease of blood glucose level  from the 14th day to the end 
of the research period. Negative control rats (DiW) had decreased of blood glucose level on the 7th day and the 14th 
day, but the blood glucose level increased again until the end of the research period.  Rats that fed glibenclamide 
drug (DiG) had a decrease of blood glucose level on the 14th day.  However, this blood glucose level was found to 
be increase on the 21th day before decreasing again at the end of the research period. 
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 Figure 2 showed blood glucose of preventive rats group (PR1). The rats had hyperglycemia 2 to 3 days 
after. Once the conditions of hyperglycemia (blood glucose >200 mg/dl) were obtained, the rats were given roselle 
again until the 23rd or 24th days.  These rats were found to suffer from hyperglycemia  from the 13th days to 18th 
days before decreasing in blood glucose until the end of the experiment. 
 
 
Figure 2. Average blood glucose of rats (PR1), given roselle extract 72 mg/ml/200g wb for 10 days,. Day 11th was 
the  induction time with STZ. After 3 days rats had hyperglycemia and  were continued  to receive roselle until day 
23. 
Table 1 showed an increase of insulin in the group of rats with roselle dose 1 and dose 2 (DiR1 and DiR2), 
but this increase did not correlate with a decrease in blood glucose levels (Figure 1).  Insulin increase was not able to 
lower blood glucose levels. This indicated the occurrence of insulin resistance that was characterized by type 2 
diabetes mellitus. Insulin resistance is a decrease in the ability of insulin to bring glucose on the muscle cells and 
adipose cells, and to reduce the ability of the liver in producing glucose [4]. 
 
Table 1. The average  of inflammatory compounds on rat spleen cells and content of insulin in rats plasma 
Treatment  Protein content 
(µg/g) 
 TNF- α (pg/µg)       IL-6 (pg/ µg) Insulin (ng/ml) 
SG 49250 1.0569±0.0874a 1.7298±0.4412 a  0.1968 ± 0.0486ab  
DiW 89498 1.7404± 0.1479 a 3.4731± 0.9200 a 0.1286 ± 0.0337 a  
PR1 86194 1.5537±0.3533 a  3.2595± 0.9443 a 0.3516 ± 0.1528 ab 
DiG 52826 1.3646 ± 0.5846 a 2.7845± 0.9988 a 0.3504 ± 0.1853 ab 
DiR1 85258 1.3534 ± 0.3998 a - 0.4433 ± 0.1802b 
DiR2 79955 1.1975 ± 0.3519 a 3.2801±0.2917 a 0.2918 ± 0.1083 ab 
Values (Mean± SE) with different superscripts in  a colom differ significantly (P<0.05); n=4 
*control normal (SG); negative  (DiW);; roselle 72 mg/day/200g wb (DiR1); roselle 288 mg/day/200g wb (DiR2); preventive rats  (PR1); 
glibenclamide (DiG). 
 
Insulin resistance can be caused by damage of either insulin receptors or of insulin itself [14]. One of the 
causes of insulin resistance is inflammatory compounds such as IL-6 and TNF-α  that increased in diabetes. 
According to Sattar et al. [15], TNF-α and IL-6 would increase on rats with either obesity or resistant insulin 
conditions. IL-6 induced a number of glucocorticoid receptors, increased circulation of glucagon concentration and 
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adipose paracrine effect to decrease insulin action. TNF-α may function as a mediator of insulin resistance because 
this cytokine can damage the insulin receptor (IR) and insulin receptor substrate (IRS) and then it can inhibit insulin 
signal. TNF-α stimulated the expression of SOCS (suppressor of cytokine signal) which binded either IRS1 or IRS2 
and mediated damage [16]. As a result, insulin could not take glucose into the muscle cells and adipose tissue, 
therefore glucose levels in blood plasma would increase. As its compensation, the β cells of the pancreas would 
produce excessively insulin and caused hyperinsulinemia. This condition then can lead to vascular inflammation and 
finally insulin resistance [4,6]. 
Table 1 showed  TNF-α compounds data were not significantly different, but the levels of TNF-α roselle 
group 1 (DiR1) and group 2 rats roselle (DiR2) tended to be lower than groups of negative rats  (DiW). The content 
of TNF-α on group of glibenclamide rats (DiG) (1.3646 ± 0.5846 pg /µg) was similar to group of  rats with roselle 1 
(1.3534 ± 0.3998 pg/µg).  Table 1 showed  IL-6 data did not differ significantly. However, group of diabetic rats 
(DiW, PR1, DiG and DiR2) tended to have a higher level of IL-6  than of normal rats (SG). 
 Diabetic rats (DiW) had the least  amount of insulin and the highest   level of TNF-α and  IL-6  among 
other groups of rats. This is likely because inflammatory compound TNF-α leads to β-cell apoptosis. High 
concentration of inflammatory cells may cause apoptosis in β-cell which can lead to either lowering in number of 
cells of insulin-producer or insulin decrease [6,17]. 
Group of diabetic rats (DiW) had higher levels of both IL-6 and TNF-α than other groups. Groups of 
diabetic rats had hyperglycemia (blood glucose> 250 mg / dl). This condition causes high oxidative stress due to the 
excessive production of free radicals (ROS) that has not been supported by antioxidant defenses in the body. 
According Virgolici et al. [18] the increased levels of inflammation were associated with the increased oxidative 
stress. Diabetic conditions could increase inflammatory compounds such as TNF-α and IL-6. The increase of 
inflammatory compounds related to the increase in BMI (Body Mass Index) and insulin resistant [3]. Other studies 
mentioned the plasma of people who were obese and got type 2 diabetes mellitus had the high concentrations of IL-6 
[19]. 
On the diabetic condition (DiW), an increase of superoxide can activate protein kinase C (PKC) [19].  PKC 
plays a role to activate cytokines. This causes an increase of cytokines levels in the study of TNF-α and IL-6 in the 
group of diabetic rats. Chang et al. [9] furthermore stated that diabetes mellitus may activate NF-κB (Nuclear factor 
kappa B) that was responsible for the production of several inflammatory compounds in which the expression of 
genes was regulated by proinflammatory cytokines, growth factors, and adhesion molecules. 
Table 1 showed the rat groups of roselle (DiR1 and DiR2) tended to a lower value of TNF-α than the group 
of diabetic rats (DiW) Glibenclamide rat groups (DiG) had the same compounds of TNF-α as the group of rats DiR1 
and DiR2. In this study, glibenclamide also has the ability to decrease the levels of inflammatory TNF-α. Table 1 
showed all rats with diabetes had an increased level of inflammatory compounds IL-6, but the provision of rosella 
extract did not give effect to a decrease of the inflammatory compounds level.
TNF-α decreasing in the group of diabetic rats with  roselle (DiR1 and DiR2) was expected because of the 
content of antioxidants that existed in roselle extract. Roselle contains anthocyanins, vitamin C, tannins, steroids, 
hidroxyquinon phenols and saponins. According to Giriwono et al. [7], 10% fermented barley supplementation 
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containing polyphenolic compounds might decrease 8OHDG levels on the plasma, and inhibited the increased levels 
of NO (nitric oxide) in plasma that associated with an increased inflammatory system.  
The antioxidant activity of polyphenolic compounds existing on fermented barley would inhibit the 
propagation of ROS that would induce inflammation and organ damage due to induce of microbial 
lipopolysaccharide. Antioxidants on fermented barley could either suppress inflammatory cytokine levels on plasma 
(IL-6, IL-1β, TNF-α) or lower concentrations of NO plasma. Extracted roselle is also anti-inflammatory, analgesic, 
and has antipyretic activity on experimental animal [20]. The decreasing level of inflammatory compounds was also 
caused by increasing levels of liver antioxidant enzymes as reported by Ebaid et al. [8] that whey protein given to 
diabetic rats led to increasing levels of glutathione in the liver and decreasing inflammatory compounds. According 
to Okoko and Ibiba [21], extracted roselle can increase the enzyme of glutathione peroxidase (GSH) and catalase as 
well as lower the levels of TBARS (thiobarbituric Acid Reactive Substances). The research done by Chang et al. [9], 
the antioxidant compound found in grapes and berries were resveratrol that have ability of resveratrol as an anti-
inflammatory of gene expression through suppression of gene expression on the strip of NF-κB and gene expression 
of cytokine IL-1β. Resveratrol was given to diabetic rats that were induced by streptozotocin. They further stated 
that resveratrol can prevent an excessive production of ROS due to its ability to capture free radicals. Research by 
Rytter [10] showed that giving α-carotene, β-carotene, lutein and lycopene may reduce levels of IL-6 on patients of 
diabetes. 
This study showed that giving extracted rosella tended to have ability for decreasing inflammatory 
compounds. A decrease of inflammatory compounds could be expected for increasing insulin receptor sensitivity 
and repairing blood sugar taking into cells. According to Donath et al. [17] a decrease of inflammation in pancreatic 
β cells closely associated with the increase proinsulin synthesis to be insulin and improved insulin sensitivity and 
pancreatic β cell mass. 
Conclusion 
Diabetes causes elevated levels of inflammatory compounds. Groups of diabetic rats were given a dose of 
72 mg roselle / day / 200 g BW and 288 mg / day / 200 g BW tended to be lower levels of TNF-α. However, the 
provision of rosella in diabetic rats did not affect the levels of IL-6. Antioxidant compounds contained in roselle can 
suppress or reduce levels of free radicals and cause decreased levels of TNF-α. This shows that the alleged roselle 
tend to reduce the level of inflammation, so that the impact of continuous severity due to inflammation can be 
suppressed. 
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